TY  - GEN
AU  - Bojang,Kalifa
AU  - Milligan,Paul
AU  - Pinder,Margaret
AU  - Doherty,Tom
AU  - Leach,Amanda
AU  - Ofori-Anyinam,Opokua
AU  - Lievens,Marc
AU  - Kester,Kent
AU  - Schaecher,Kurt
AU  - Ballou,W Ripley
AU  - Cohen,Joe
TI  - Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia
SN  - 1554-8619
PY  - 2009///1009
KW  - Adolescent
KW  - Adult
KW  - Animals
KW  - Antibodies, Protozoan
KW  - blood
KW  - Antigens, Protozoan
KW  - immunology
KW  - Endemic Diseases
KW  - prevention & control
KW  - Follow-Up Studies
KW  - Gambia
KW  - epidemiology
KW  - Humans
KW  - Malaria Vaccines
KW  - adverse effects
KW  - Malaria, Falciparum
KW  - Male
KW  - Middle Aged
KW  - Plasmodium falciparum
KW  - Rabies Vaccines
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.4161/hv.5.4.7050
ER  -